Analysis of the Mechanism of Graft–Versus–Host–Like Disease in B6 Mice with Transferred B6-1Pr Spleen Cells

References

• Morton J I, Siegel B V. Transplantation of autoimmune potential. 1. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proc Natl Acad Sci USA 1974; 71: 2162–5
   PubMed Web of Science ®Google Scholar
• Morton J I, Siegel B V. Early autoantibody formation in lethally irradiated or drug-treated H-2-compatible recipients of pre-autoimmune NZB bone marrow or fetal liver cells. Transplantation 1974; 17: 624–6
   PubMedGoogle Scholar
• Jyonouchi H, Kincade P W, Good R A, Fernandes G. Reciprocal transfer of abnormalities in clonableB lymphocytes and myeloid progenitors between NZB and DBA/2 mice. J Immunol 1981; 10: 247–50
   Google Scholar
• Akizuki M, Reeves J P, Steinberg A D. Expression of autoimmunity by NZB/NZW marrow. Clin Immunol Immunopathol 1978; 127: 1232–5
   Google Scholar
• Eisenberg R A, Izui S, McConahey P J, Hang L, Peters C J, Theofilopoulos A N, Dixon F J. Male determined accelerated autoimmune disease in BXSB mice. Transfer by bone marrow and spleen cells. J Immunol 1980; 125: 1032–6
   PubMed Web of Science ®Google Scholar
• Theofilopoulos A N, Dixon F J. Etiopathogenesis of murine SLE. Immunological Rev 1981; 55: 179–216
   PubMed Web of Science ®Google Scholar
• Theofilopoulos A N. Role of the thymus in murine lupus cellular transfer of the disease. Arthritis Rheum 1982; 25: 726–33
   PubMedGoogle Scholar
• Onoe K, Fernandes G, Good R A. Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J Exp Med 1980; 151: 115–32
   PubMed Web of Science ®Google Scholar
• Muto M, Sado T, Aizawa S, Kamisaku H, Kubo E. Bone marrow transplantation across the major histocompatibility barrier in specific-pathogen-free mice: Effects of intact versus T cell-depleted bone marrow on the expression of anti-host reaction in the recipient spleens. J Immunol 1981; 127: 2421–5
   PubMedGoogle Scholar
• Vallera D A, Soderling C CB, Carlson G J, Kersey J H. Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complete-ment or antibody alone. Transplantation 1981; 31: 218–22
   PubMed Web of Science ®Google Scholar
• Murphy E D, Roths J B. Autoimmunity and lymphoprolifera-tion: Induction by mutant gene lpr, and acceleration by a male associated factor in strain BXSB mice. Genetic Control of Autoimmune Disease, N R Rose, P E Bigazzi, N L Warner. Elsevier/North-Holland, Amsterdam 1978; 207–20
   Google Scholar
• Theofilopoulos A N, Balderas R S, Gozes Y, Aguado T, Hang L M, Morrow P R, Dixon F J. Association of lpr gene with graft-vs.-hosl disease-like syndrome. J Exp Med 1985; 162: 1–18
   PubMedGoogle Scholar
• Fujiwara M, Kariyonc A. One-way occurrence of graft-versus-host disease in bone marrow chimeras between congenic MRL mice. Immunology 1984; 53: 251–6
   PubMedGoogle Scholar
• Okuyama H, Kobayashi S, Harada H, Kawaguchi Y, Sekikawa I. Treatment of donor cells with L-leucyl-L-leucine methyl ester prevents induction of graft-vs-host-like reaction in [lpr/1pr → +/+] chimera. Clin Immunol Immunopathol 1990; 54: 26–39
   PubMedGoogle Scholar
• Gillis S, Ferm M M, Ou W, Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 1978; 120: 2027–32
   PubMed Web of Science ®Google Scholar
• Theofilopoulos A N, Dixon F J. Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37: 269–390
   PubMed Web of Science ®Google Scholar
• Roths J B, Murphy E D, Lzui S, Kelley V E. Modification of expression of lpr by background genome. Fed Proc 1983; 42: 1075
   Google Scholar
• Rappaport H, Khalil A, Halle-Pannenko O, Pritchard L, Dantchev D, Mathe G. Histopathologic sequence of events in adult mice undergoing lethal graft-versus-host reaction developed across H-2 and/or non-H-2 histocompatibility barriers. Amer J Pathol 1979; 96: 121–36
   PubMedGoogle Scholar
• Korngold R, Sprent J. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med 1978; 148: 1687–98
   PubMed Web of Science ®Google Scholar
• Hamilton B L. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens. J Immunol 1987; 139: 2511–5
   PubMed Web of Science ®Google Scholar
• Sprent J, Schaefer M, Lo D, Korngold R. Properties of purified T cell subsets II. In vivo responses to class I vs. class II H-2 differences. J Exp Med 1986; 163: 998–1011
   PubMed Web of Science ®Google Scholar
• Shearer G M, Levy R B. Graft-vs-.host-associated immune suppression is activated by recognition of allogeneic murine I-A antigens. J Exp Med 1983; 157: 936–46
   PubMed Web of Science ®Google Scholar
• Rolink A G, Pals S T, Gleichmann E. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F, recipients carrying mutations at H-2K and/or I-A. J Exp Med 1983; 157: 755–71
   PubMed Web of Science ®Google Scholar
• Hamilton B L, Bevan M J, Parkman R. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens. J Immunol 1981; 126: 621–5
   PubMed Web of Science ®Google Scholar
• Fujiwara M, Kariyone A. Resistant nature of T cells of autoimmune mice to tolerance induction with human serum albumin. Immunology 1982; 47: 573–9
   PubMedGoogle Scholar
• Amagai T, Cinader B. Resistance of MRL/Mp-lpr/lpr mice to tolerance induction. Eur J Immunol 1981; 11: 923–6
   PubMedGoogle Scholar
• Kappler J W, Wade T, White J, Kushnir E, Blackman M, Bill J, Roehm N., Marrack P. A T cell receptor V/y segment that imparts reactivity to a class II major histocompatability complex product. Cell 1987; 49: 263–71
   PubMed Web of Science ®Google Scholar
• Kappler J W, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273–80
   PubMed Web of Science ®Google Scholar
• Kappler J W, Staerz U, White J, Marrack P C. Self-tolerance eliminates T cells specific for Mis-modified products of the major histocompatibility complex. Nature 1988; 332: 35–40
   PubMed Web of Science ®Google Scholar
• MacDonald H R, Schneider R, Lees R K, Howe R C, Acha-Orbea H, Festenstein H, Zinkernagel R M, Hengartner H. T-cell receptor Vft use predicts reactivity and tolerance to M/.va-encoded antigens. Nature 1988; 332: 40–5
   PubMed Web of Science ®Google Scholar
• Kotzin B L, Babcock S K, Herron L R. Deletion of potentially self-reactive T cell receptor specificities in L3T4-, Lyt-2- T cells of Ipr mice. J Exp Med 1988; 168: 2221–9
   PubMed Web of Science ®Google Scholar
• Singer P A, Balderas R S, McEvilly R J, Bobardt M, Theo-Filopoulos A N. Tolerance-related Vft clonal deletions in normal CD4- 8-, TCR-αβ+ and abnormal Ipr and gld cell populations. J Exp Med 1989; 170: 1869–77
   PubMed Web of Science ®Google Scholar
• Mountz J D, Smith T M, Toth K S. Altered expression of self-reactive T cell receptor Vft regions in autoimmune mice. J Immunol 1990; 144: 2159–66
   PubMed Web of Science ®Google Scholar
• Simonsen M. Graft versus host reactions. Their natural history, and applicability as tools of research. Progr Allergy 1962; 6: 349–467
   PubMedGoogle Scholar
• Holda J H, Maier T, Claman H N. Murine graft-versus-host disease across minor barriers: Immunosuppressive aspects of natural suppressor cells. Immunol Rev 1985; 88: 87–105
   PubMed Web of Science ®Google Scholar
• Tutshka P J, Hess A D, Beshorner W E, Santos G W. Suppressor cells in transplantation tolerance. I. Suppressor cells in the mechanism of tolerance in radiation chimeras. Transplantation 1981; 32: 203–9
   PubMedGoogle Scholar
• Pickel K, Hoffmann M K. The Ly phenotype of suppressor T cells arising in mice subjected to a graft-versus-host reaction. J Exp Med 1977; 145: 1169–75
   PubMed Web of Science ®Google Scholar
• Shand F L. Ly and la phenotype of suppressor T cells induced by graft-vs.-host reaction. Eur J Immunol 1977; 7: 746–8
   PubMedGoogle Scholar
• Gleichmann E, Gleichmann H. Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like disease. J Invest Dermatol 1985; 85(Supplement)115s–20s
   PubMedGoogle Scholar
• Pickel K, Hoffmann M K. Suppressor T cells arising in mice undergoing a graft-vs-host response. J Immunol 1977; 118: 653–6
   PubMed Web of Science ®Google Scholar
• Shand F L. Analysis of immunosuppression generated by the graft-versus-host reaction II. Characterization of the suppressor cell and its mechanism of action. Immunology 1976; 31: 943–51
   PubMedGoogle Scholar
• Holda J H, Maier T, Claman H N. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena. J Immunol 1985; 134: 1397–402
   PubMedGoogle Scholar
• Rolink A G, Radaszkiewicz T, Pals S T, Van der Meer W GJ, Gleichmann E. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs.-host disease. J Exp Med 1982; 155: 1501–22
   PubMedGoogle Scholar
• Gleichmann E, Pals S T, Rolink A G, Radaszkiewicz T, Gleichmann H. Graft-versus-host reactions: clues to the etio-pathology of a spectrum of immunological diseases. Immunology Today 1984; 5: 324–32
   PubMedGoogle Scholar